COVID-19 PrEP HCW HCQ Study
NCT04354870
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
130
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Hydroxychloroquine (HCQ)
Sponsor
NYU Langone Health